ClinicalTrials.gg
Not yet recruitingNCT07801677Updated Sep 3, 2026

The Effect of Vertically Coronally Advanced Flap With Sub-epithelial Connective Tissue Graft Versus Coronally Advanced Flap With Sub-epithelial Connective Tissue Graft on Gingival Recession.

An interventional study of Vertically Coronally Advanced flap combined with sub-epithelial connective tissue graft and Coronally Advanced flap combined with sub-epithelial connective tissue graft in Gingival Recession Defects, sponsored by Cairo University. Not yet recruiting at 1 site in Egypt. Open to participants aged 18 Years to 80 Years. Per ClinicalTrials.gov, last updated 2026-09-03.

Sponsored by Cairo University · Not applicable, Interventional, and Treatment

Phase
Not applicable
Study type
Interventional
Enrollment
26
Allocation
Randomized
Ages
18 Years to 80 Years
Sex
All
01

Where this study stands

Counted across the records on this site · 2026-11-12

Among 35 studies in Gingival Recession by Cairo University — 14 open to participants now, 14 under way, 2 of them phase 3. Gingival Recession · Cairo University.

Planned enrollment
13th of 35
26 · median 24
Started
2026
with 4 others
No phase
30 of 35
11 open now
Primary completion
2027-03
later than 11 of 13 live
Registered
34th of 35
by date

Among the 35 studies in Gingival Recession by Cairo University, this one is the 13th largest by planned enrollment, is one of 5 that started in 2026, is one of 30 with no phase, reaches primary completion later than 11 of the 13 other live ones, and was the 34th registered.

By phase

35 studies; the count open now beside each. This study's row is marked.

No phasethis study30 · 11 open
Phase 1/22 · 1 open
Phase 2/32 · 2 open
Phase 41 · 0 open

By the year they started

First in 2014; this study’s year is marked. 5 started in 2026.

Size and results

Median enrollment 24 across the 35 interventional studies. Of the 8 that completed or were terminated, 1 (13%) have results posted.

Was this useful?
Watch this landscapeDownload CSVWith an account: a weekly mail of what changed among 35 studies in Gingival Recession by Cairo University, or all of them as a file.
02

Study summary

The aim of this randomized clinical trial will be to assess the change in recession depth after using a vertically coronally advanced flap with sub-epithelial connective tissue graft compared to a coronally advanced flap with sub-epithelial connective tissue graft after 6 months.

Read the detailed description

To test new approaches for root coverage for the treatment of RT1 and RT2 gingival recession.

03

Conditions studied

  • Gingival Recession Defects

Browse trials for

Keywords

  • V-CAF
  • CAF
  • Recession
  • Root coverage
  • SCTG
04

Who can participate

Ages eligible
18 Years to 80 Years
Sexes eligible
All
Accepts healthy volunteers
No

Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.

Inclusion criteria

    • Age ≥ 18 years.

      • Systemically healthy.
      • Non-smokers.
      • Full-mouth plaque index (PI) and full-mouth bleeding on probing (BOP) score of ≤ 15%.
      • Presence of identifiable CEJ.
      • Absence of non-carious cervical lesions.
      • Mature permanent tooth in the aesthetic zone.
      • At least one recession defect type RT1 and/ or RT2 in the upper or lower jaw.
      • Thin gingival phenotype (GT \< 0.8 mm) via probe transparency method.
      • A minimum of (2 mm KTW).

Exclusion criteria

Exclusion Criteria:

  • Any systemic disease.
  • Pregnancy or lactation.
  • Cairo RT3 recession defects.
  • Teeth with active orthodontic treatment.
  • Previous periodontal surgery in the area.
  • Use of any drugs that might lead to gingival enlargement.
  • Smoking.
  • Caries, restoration, mobility, unstable endodontic condition, and malocclusion in teeth undergoing treatment.
05

Study design

Phase
Not applicable
Primary purpose
Treatment
Allocation
Randomized
Intervention model
Parallel assignment
Masking
Double (Participant, Outcomes assessor)
Enrollment
26 participants (estimated)

Study arms

  • Active comparator
    Coronally Advanced flap combined with sub-epithelial connective tissue graft

    The combination of a SCTG with CAF was regarded as the gold standard for root coverage procedures

    Procedure: Coronally Advanced flap combined with sub-epithelial connective tissue graft

  • Experimental
    Vertically Coronally Advanced flap combined with sub-epithelial connective tissue graft

    Vertically coronally advanced flap combined with a subepithelial connective tissue graft for the treatment of gingival recession defects. The procedure involves preparation and coronal advancement of a vertically designed flap to cover the exposed root surface, followed by placement of a subepithelial connective tissue graft beneath the flap to enhance soft-tissue thickness and root coverage.

    Procedure: Vertically Coronally Advanced flap combined with sub-epithelial connective tissue graft

Interventions

  • ProcedureVertically Coronally Advanced flap combined with sub-epithelial connective tissue graft

    Vertically coronally advanced flap combined with a subepithelial connective tissue graft for the treatment of gingival recession defects. The procedure involves preparation and coronal advancement of a vertically designed flap to cover the exposed root surface, followed by placement of a subepithelial connective tissue graft beneath the flap to enhance soft-tissue thickness and root coverage.

  • ProcedureCoronally Advanced flap combined with sub-epithelial connective tissue graft

    The combination of a SCTG with CAF was regarded as the gold standard for root coverage procedures

06

What researchers measure

Primary outcomes

  1. Change in recession depth (mm)

    Change in recession depth in millimeters will be measured using a UNC-15 periodontal probe as the distance from the cementoenamel junction towards the most apical extension of the gingival margin

    Time frame: at Baseline and 6 months

Secondary outcomes

  1. Gingival Recession Width (mm)

    Gingival recession width will be measured in millimeters using a UNC-15 periodontal probe as the distance from the base of the mesial to the distal papillae along the cementoenamel junction.

    Time frame: at baseline and 6 months

  2. Keratinized Tissue Width (mm)

    Keratinized tissue width will be measured in millimeters using a UNC-15 periodontal probe from the gingival margin at the deepest recession point till the mucogingival junction (MGJ), which will be identified using the roll technique

    Time frame: at Baseline and 6 months

  3. Keratinized Tissue Height (mm)

    Keratinized tissue height will be measured in millimeters using a UNC-15 periodontal probe from the gingival margin to the mucogingival junction.

    Time frame: at Baseline and 6 months

  4. Probing Depth (mm)

    Probing depth will be measured in millimeters using a UNC-15 periodontal probe as the distance from the base of the gingival crevice to the marginal gingiva.

    Time frame: at Baseline and 6 months

  5. Gingival Thickness (mm)

    Gingival thickness will be measured in millimetres using endodontic spreader no. 15 with a silicon disk stopper will be performed apical to the gingival margin by 2 mm at the middle of the long axis of the tooth mesio-distally using a UNC-15 periodontal probe.The depth of penetration will be measured using a ruler with precision up to the nearest 0.5 mm.

    Time frame: at Baseline and 6 months

  6. Recession Reduction (mm)

    Recession reduction will be calculated by comparing the initial gingival recession depth and gingival depth after treatment using a UNC-15 periodontal probe.

    Time frame: at Baseline and 6 months

  7. Clinical Attachment Level (mm)

    Clinical attachment level will be identified using a UNC-15 periodontal probe as the distance from the cementoenamel junction to the bottom of the gingival sulcus.

    Time frame: at Baseline and 6 months

  8. Complete Root Coverage (%)

    Complete root coverage will be assessed by calculating the percentage of cases exhibiting a gingival margin that was either level with or positioned coronally to the cementoenamel junction in each group.

    Time frame: at 6 months

  9. Bleeding on Probing (+/-)

    Bleeding on probing (BOP) will be measured using an UNC-15 periodontal probe, gently probing the gingival crevice, beginning inter-proximally from the mesial aspect and moving towards the distal. A positive finding for BOP will be recorded when bleeding occurred within 10s.

    Time frame: at Baseline and 6 months

  10. Plaque Index (scores 0, 1, 2, 3)

    Plaque index will be determined by drying the teeth in each quadrant with a gentle air blast, where the visibility of dental plaque and supragingival calculus will be noted. Each four tooth surfaces (buccal, lingual, mesial and distal) will be scored from 0 to 3, then scores of the four areas will be added and divided by four to give the average plaque index for each tooth. Scores: 0 : No plaque 1 : A film of plaque adhering to the free gingival margin and adjacent area of the tooth. The plaque may be seen in situ only after application of disclosing solution or by using the probe on the tooth surface. 2: Moderate accumulation of soft deposit s within the gingival pocket, or the tooth and gingival margin, which can be seen with the naked eye. 3: Abundance of soft matter within the gingival pocket and/or on the tooth and gingival margin.

    Time frame: at Baseline and 6 months

  11. Post-Operative Pain (VAS) Visual Analogue Scale Questionnaire

    Post-operative pain will be indirectly evaluated on the basis of the mean consumption (in mg) of analgesics (ibuprofen). A questionnaire will be given to each patient; it will be divided into two parts to be completed in different time periods: the first part, regarding the post-operative discomfort and bleeding will be completed 1 week after the surgery based on a visual analogue scale of 100 mm.Postoperative pain will be assessed using a 100-mm Visual Analogue Scale, ranging from 0 mm (no pain) to 100 mm (worst imaginable pain), with higher scores indicating greater pain.

    Time frame: Surgical day and days 1, 3, 7, and 14 after surgery

  12. Patient Esthetic Satisfaction (RES) Root Coverage Esthetic Score

    Patient aesthetic satisfaction will be assessed using the root coverage esthetic score (RES) at the 6 months follow up visit. The following five parameters will be evaluated: gingival margin level (0 = failure of root coverage; 3 = partial root coverage; 6 = complete root coverage), marginal tissue contour (0 = irregular; 1 = proper), soft tissue texture (0 = presence of scar/keloid; 1 = absence of scar/ keloid), mucogingival junction (MGJ) (0 = MGJ not aligned; 1 = MGJ aligned), and gingival color (0 = color differs from adjacent teeth; 1 = normal color and integration). A total RES score will be calculated by adding these 5 components

    Time frame: at 6 months

  13. Mean Percentage of Root Coverage (mRC) %

    Mean percentage of root coverage (mRC) will be calculated after 6 months as the percentage reduction in gingival recession depth from baseline to 6 months post-treatment, using the following formula: mRC (%) = \[(RD₀ - RD6) / RD₀\] × 100, where RD₀ represents the gingival recession depth at baseline and RD6 represents the gingival recession depth at 6 months post-treatment.

    Time frame: (subtraction of gingival RD at baseline from gingival RD at 6 months divided by gingival RD at baseline) multiplied by 100

07

Study locations

1 site
  • Faculty of dentistry cairo ubiversity
    Cairo, 11562, Egypt
08

References and documents

Individual participant data

Plan to share: Yes

Supporting information: Study protocol, Statistical analysis plan, Informed consent form, Clinical study report

No publications or documents are linked to this record.

09

Timeline

Tracking since Sep 25, 2026
ElapsedEstimatedEstimated, not yet reachedSimilar studies: half by the dot; the band is the middle halfHalf of similar studies reached it by the dot; the band is the middle half, from a quarter to three quarters

Start is estimated for Sep 2026; primary completion for Mar 2027, 6 months later.

Of 233 non-industry interventional studies with no phase under Gingival Recession, half reached primary completion within 19 months of starting (the median), counting those still running; a quarter within 11 and three quarters within 30. This study's planned 6 months is below that.

Counting every sponsor, half of 235 studies reached it within 19 months; a quarter within 11 and three quarters within 30.

How these figures are worked out, and which studies are left out of them.

Registered
Aug 11, 2026
First posted
Sep 3, 2026
StartEst.
Sep 2026
Primary completionEst.
Mar 2027
CompletionEst.
Nov 2027
Last update
Sep 3, 2026
What these dates mean
Start.
When the first participant enrolled; while estimated, when the study expects to open to recruitment.
Primary completion.
When the last participant was examined or treated to collect data for the study's main question, its primary outcome. A study that stopped early gives the date its data collection stopped.
Completion.
When the last participant's last visit took place, for every outcome, secondary ones and side effects included: the end of the study. Often later than primary completion, sometimes the same day.
Actual and Est.
Actual means the registry says the date has happened. Est. (estimated) is a date the sponsor plans or expects. It can still move, and the sponsor is expected to change it to actual once it has passed.
No changes since tracking began. The registry record was last updated on Sep 3, 2026, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
10

Registry details

Key details

Study ID
NCT07801677
Lead sponsor
Cairo University
Responsible party
Mai Magdy Abu El Eneen (Principal Investigator, Cairo University) — Principal investigator
First posted
Sep 3, 2026
Start date
Sep 2026 (estimated)
Primary completion
Mar 2027 (estimated)
Completion
Nov 2027 (estimated)
Last update
Sep 3, 2026

Study contacts

Mai Magdy Abu El Eneen, PHD candidate
Contact
mai.abueleneen@dentistry.cu.edu.eg
0201123864563
Mai Magdy Abu El Eneen, PHD candidate
principal investigator · Cairo University

Oversight

Data monitoring committee
Yes
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is not yet recruiting, as verified in Aug 2026. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion